JPH0215544B2 - - Google Patents

Info

Publication number
JPH0215544B2
JPH0215544B2 JP55010182A JP1018280A JPH0215544B2 JP H0215544 B2 JPH0215544 B2 JP H0215544B2 JP 55010182 A JP55010182 A JP 55010182A JP 1018280 A JP1018280 A JP 1018280A JP H0215544 B2 JPH0215544 B2 JP H0215544B2
Authority
JP
Japan
Prior art keywords
sulfonamide
intermediate product
acid
phenylethylamine
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP55010182A
Other languages
Japanese (ja)
Other versions
JPS55167278A (en
Inventor
Daro Jorujo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WASSERMANN SpA A
Original Assignee
WASSERMANN SpA A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WASSERMANN SpA A filed Critical WASSERMANN SpA A
Publication of JPS55167278A publication Critical patent/JPS55167278A/en
Publication of JPH0215544B2 publication Critical patent/JPH0215544B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、とくに少量の投与で血糖低下作用を
示すスルホニル尿素の製造に有用なカルボキシア
ミドエチルベンゼン−4−スルホンアミドの製造
方法に関するものである。一般式 (式中、Rは5−置換−イソキサゾール3−カ
ルボン酸残基でありかつR1は直鎖または分岐状
のC3以下のアルキル残基であるかまたはシクロ
アルキルである)で表される上記スルホニル尿素
は一般的にはカルボキシアミドエチルベンゼン−
4−スルホンアミド()とアルキルイソシアネ
ート()の反応、即ち次式: (式中、RおよびR1は上記に定義したものと
同様である)によつて製造される。
[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a method for producing carboxyamidoethylbenzene-4-sulfonamide, which is useful for producing a sulfonylurea that exhibits a hypoglycemic effect particularly when administered in a small amount. . general formula (wherein R is a 5-substituted-isoxazole 3-carboxylic acid residue and R 1 is a linear or branched C 3 or less alkyl residue or cycloalkyl) Sulfonylureas are generally carboxyamidoethylbenzene-
The reaction between 4-sulfonamide () and alkyl isocyanate (), i.e., the following formula: (wherein R and R 1 are as defined above).

スルホニル尿素()の工業的製造の収率およ
びコストは、必要な純度をもつ、対応するカルボ
キシアミドエチルベンゼン−4−スルホンアミド
()の製造の収率およびコストに強く依存する。
The yield and cost of the industrial production of the sulfonylurea () strongly depends on the yield and cost of the production of the corresponding carboxyamidoethylbenzene-4-sulfonamide () with the required purity.

公知の技術にしたがつて、カルボキシアミドエ
チルベンゼン−4−スルホンアミド()は酸R
−COOHの塩化物()と4−(β−アミノエチ
ル)−ベンゼンスルホンアミド塩酸塩()との
間の反応によつて調製される。
According to known techniques, carboxyamidoethylbenzene-4-sulfonamide () is prepared from the acid R
It is prepared by the reaction between the chloride of -COOH () and 4-(β-aminoethyl)-benzenesulfonamide hydrochloride ().

いずれにしても公知技術の一般的な教示によれ
ば、上記反応に必要な4−(β−アミノエチル)−
ベンゼンスルホンアミド()は、βフエニルエ
チルアミン()のスルホクロル化、アミド化お
よびかくして得られた中間体アミドの最終酸加水
分解によつて得られる。
In any case, according to the general teachings of the prior art, the 4-(β-aminoethyl)-
Benzenesulfonamide () is obtained by sulfochlorination of β-phenylethylamine (), amidation and final acid hydrolysis of the intermediate amide thus obtained.

β−フエニルエチルアミン()のアミノ基が
上記反応に使用される前に、例えば無水酢酸によ
るβ−フエニルエチルアミン()の処理(アセ
チル化)によつて、正確に保護されねばならない
ことを考慮すると、4−(β−アミノエチル)−ベ
ンゼンスルホンアミド()、とくにその塩酸塩
の形での調製には、公知の技術の教示によれば、
以下の反応図式によつて理解できるような5つの
工程を必要とする。
Taking into account that the amino group of β-phenylethylamine () must be protected precisely before it is used in the above reaction, e.g. by treatment of β-phenylethylamine () with acetic anhydride (acetylation). For the preparation of 4-(β-aminoethyl)-benzenesulfonamide (), especially in the form of its hydrochloride, according to the teachings of the known art, then,
Five steps are required as can be understood by the reaction scheme below.

第6の工程、すなわち塩酸塩()と適当な酸
RCOOHの塩化物()の反応により、所望のカ
ルボキシアミドエチルベンゼン−4−スルホンア
ミド()を得る。
Sixth step, i.e. hydrochloride () and suitable acid
Reaction of RCOOH with the chloride () gives the desired carboxamidoethylbenzene-4-sulfonamide ().

したがつて、この化合物()の製造に、殊に
工業的観点からみれば個々の反応の部分的収率お
よび特別な中間生成物の高い純度の必要性にしば
られている限り必然的に劣つている。
Therefore, there are necessarily disadvantages in the preparation of this compound (), especially from an industrial point of view, which is bound by the need for partial yields of the individual reactions and high purity of the particular intermediate products. It's on.

本発明の基本的問題はそれゆえ、生成歩留りを
かなり良くしかつそれを得る費用、かつしたがつ
て得られるスルホニル尿素()の生成歩留りお
よび費用を減少するように、カルボキシアミドエ
チルベンゼン−4−スルホンアミド()の製造
に今までに必要とした反応の数を著しく減少させ
ることにある。
The basic problem of the present invention is therefore to obtain carboxyamidoethylbenzene-4-sulfonate in a manner that significantly improves the production yield and the cost of obtaining it, and thus reduces the production yield and cost of the sulfonylurea () obtained. The aim is to significantly reduce the number of reactions hitherto required for the production of amides ().

この問題は、本発明によれば、次の連続工程か
らなることを特徴とする方法によつて解決され
る。すなわち、 ・β−フエニルエチルアミンを酸RCOOHの塩化
物(Rは5−置換−イソキサゾール3−カルボン
酸残基を示す。)と反応させ、式 (Rは上記と同じ意味を有する) で表される中間生成物()を得る、 ・クロルスルホン酸による該中間生成物()の
スルホクロル化 ・濃アンモニアによるクロルスルホン化該中間生
成物のアミド化により、式 (式中、Rは上記で定義されたものに同じ)で
表されるカルボキシアミドエチルベンゼン−4−
スルホンアミドを得ること。
This problem is solved according to the invention by a method characterized in that it consists of the following successive steps. That is, by reacting β-phenylethylamine with the chloride of acid RCOOH (R represents a 5-substituted-isoxazole 3-carboxylic acid residue), the formula (R has the same meaning as above) Sulfochlorination of the intermediate product () with chlorosulfonic acid Chlorsulfonation with concentrated ammonia Amidation of the intermediate product According to the formula Carboxamidoethylbenzene-4- (wherein R is the same as defined above)
Obtaining the sulfonamide.

本発明方法の主たる利点は、公知技術の教示に
より現在まで必要な6つの段階に対して、単に3
つの段階でβ−フエニルエチルアミンから出発す
るカルボキシアミドエチルベンゼン−4−スルホ
ンアミド()の製造が可能であることにある。
したがつて、結果として生ずるカルボキシアミド
エチルベンゼン−4−スルホンアミドおよびスル
ホニル尿素は現在まで可能であつたものに比して
著しく減少した費用で製造することができる。
The main advantage of the method according to the invention is that only 3 steps are needed, compared to the 6 steps required up to now according to the teachings of the prior art.
It is possible to prepare carboxyamidoethylbenzene-4-sulfonamide () starting from β-phenylethylamine in two steps.
The resulting carboxyamidoethylbenzene-4-sulfonamides and sulfonylureas can therefore be produced at significantly reduced costs compared to what has been possible to date.

留意すべきことは、本発明方法はβ−フエニル
エチルアミンと酸RCOOHの塩化物の直接反応に
より式 で表される上記中間生成物が得られることであ
り、それ故、この中間生成物が本発明の実質的な
特徴を構成するということである。
It should be noted that the process of the present invention involves the direct reaction of β-phenylethylamine with the chloride of acid RCOOH to form the formula Therefore, this intermediate product constitutes a substantial feature of the present invention.

本発明の方法によつて得られるカルボキシアミ
ドエチルベンゼン−4−スルホンアミド()
は、古典的なすべての方法で、アルキルまたはシ
クロアルキルイソシアネート()の適当量と反
応させることによつて、ほとんど定量的に相当す
るスルホニル尿素を得ることができる。
Carboxamidoethylbenzene-4-sulfonamide () obtained by the method of the present invention
can be obtained almost quantitatively to the corresponding sulfonylureas by reacting with appropriate amounts of alkyl or cycloalkyl isocyanates () by all classical methods.

本発明の好適な態様によれば、酸RCOOHの塩
化物は、β−フエニルエチルアミンとの反応によ
つて式 の中間生成物を与える5−メチルイソキサゾール
−3−カルボキシル酸塩化物よりなるものであ
る。
According to a preferred embodiment of the invention, the chloride of the acid RCOOH is prepared by reaction with β-phenylethylamine of the formula It consists of 5-methylisoxazole-3-carboxylic acid chloride giving the intermediate product.

そのような中間生成物をスルホクロル化および
アミド化することにより、一般式 に相当するカルボキシアミドエチルベンゼン−4
−スルホンアミドを得る。
By sulfochlorination and amidation of such intermediates, the general formula Carboxamidoethylbenzene-4 corresponding to
- Obtain the sulfonamide.

この生成物とシクロヘキシルイソシアネートと
の反応により、よく知られた式 に対応するグリソールアミドの名称で知られるス
ルホニル尿素を得る。
Reaction of this product with cyclohexyl isocyanate gives the well-known formula The corresponding sulfonylurea known under the name glycolamide is obtained.

以下に本発明の実施例を説明するが、これは本
発明の範囲をそれに限定するものではない。
Examples of the present invention will be described below, but the scope of the present invention is not limited thereto.

実施例 1 フラスコ内に一般的方法で調製された無水ピリ
ジン25ml中β−フエニルエチルアミン12.56ml
(0.1モル)溶液に、5−メチルイソキサゾール−
3−カルボニルクロリド14.5g(0.1モル)を撹
拌しながらフラスコ内温度を0℃近くの値に制御
しながら滴下する。
Example 1 12.56 ml of β-phenylethylamine in 25 ml of anhydrous pyridine prepared in a conventional manner in a flask.
(0.1 mol) solution, 5-methylisoxazole-
14.5 g (0.1 mol) of 3-carbonyl chloride is added dropwise while stirring while controlling the temperature inside the flask to a value close to 0°C.

滴下後、該溶液を室温で30分間撹拌し、次いで
70℃まで加熱する。この値に達した後、温度は2
時間で室温迄下がる。
After addition, the solution was stirred at room temperature for 30 minutes and then
Heat to 70℃. After reaching this value, the temperature is 2
It will drop to room temperature in time.

フラスコの内容物を氷水に注ぎ、沈澱物を減圧
脱水し、次いで洗浄する。40℃の恒温器での乾燥
後、式 のN−(β−フエニルエチル)−5−メチルイソキ
サゾール−3−カルボキシアミドからなる粗製中
間生成物23g(収量100%)を得る。
The contents of the flask are poured into ice water and the precipitate is dried under reduced pressure and then washed. After drying in a thermostat at 40℃, the formula 23 g (100% yield) of a crude intermediate product consisting of N-(β-phenylethyl)-5-methylisoxazole-3-carboxamide are obtained.

イソプロピルエーテルで結晶化することによつ
て前記粗製生成物から出発して、理論値の約86%
の収量で中間体を得る。
Starting from the crude product by crystallization with isopropyl ether, approximately 86% of theory
The intermediate is obtained in a yield of .

この純粋な中間生成物は、水に不溶でかつ融点
89〜90℃のエタノールに可溶で、ほとんど不透明
な微晶質の白色物質である。
This pure intermediate product is insoluble in water and has a melting point of
It is a white, almost opaque, microcrystalline substance that is soluble in ethanol at 89-90°C.

シクロヘキサン−酢酸エチル(7:3)混合物
を展開液として使用してシリカゲル薄層クロマト
グラフイーにおいて、ただ1つのスポツトを認め
た。
Only one spot was observed in silica gel thin layer chromatography using a cyclohexane-ethyl acetate (7:3) mixture as the developing solution.

第2のフラスコ内で、無水クロロホルム15ml中
クロルスルホン酸3.015ml(0.044モル)の溶液を
調製し、そしてフラスコを−5℃に冷却した。こ
のクロルスルホン酸溶液に、フラスコ内の温度を
−5℃に制御しながら、無水クロロホルム20ml中
上述した純粋な中間生成物9.2g(0.04モル)を
含む溶液を滴下する。この操作終了後、フラスコ
内の温度を室温まで上昇させ、更に30分後、水と
氷の混合物中にフラスコ内容物を注ぎ、温度が0
℃を越えないように保つ。
In a second flask, a solution of 3.015 ml (0.044 mol) of chlorosulfonic acid in 15 ml of anhydrous chloroform was prepared and the flask was cooled to -5°C. A solution containing 9.2 g (0.04 mol) of the pure intermediate product described above in 20 ml of anhydrous chloroform is added dropwise to this chlorosulfonic acid solution while controlling the temperature in the flask at -5°C. After completing this operation, the temperature inside the flask was raised to room temperature, and after another 30 minutes, the contents of the flask were poured into a mixture of water and ice until the temperature reached 0.
Keep the temperature below ℃.

次ぎに、クロロホルム層を分離し、無水硫酸ナ
トリウムで乾燥し、次いで真空下で溶媒を蒸発す
る。得られた残渣(12.5g、収量92.5%)を室温
で、濃アンモニア水(28゜Be′)75mlで一夜撹拌す
る。
The chloroform layer is then separated, dried over anhydrous sodium sulfate, and then the solvent is evaporated under vacuum. The resulting residue (12.5 g, yield 92.5%) was stirred overnight at room temperature with 75 ml of concentrated aqueous ammonia (28° Be').

真空下で脱水して綿くず状沈澱を得、これを水
洗した後乾燥する。
Dehydration is performed under vacuum to obtain a fluff-like precipitate, which is washed with water and then dried.

この生成物を無水エタノール中で再結晶して式 に相当する4−〔β−(5−メチルイソキサゾリル
−3−カルボキシアミド)−エチル〕−ベンゼンス
ルホンアミド(融点219〜220℃)約10gを得る。
This product was recrystallized in absolute ethanol to give the formula Approximately 10 g of 4-[β-(5-methylisoxazolyl-3-carboxamido)-ethyl]-benzenesulfonamide (melting point 219 DEG -220 DEG C.) is obtained.

収量は理論値の約80%である。クロロホルム−
メタノール−酢酸(100:10.1)の展開液を使用
して、シリカゲル薄層クロマトグラフイーにおい
て、単一のスポツトを与えた。
The yield is about 80% of the theoretical value. Chloroform-
Single spots were generated in silica gel thin layer chromatography using methanol-acetic acid (100:10.1) eluent.

実施例 2 フラスコ中に、β−フエニルエチルアミン
12.11g(0.1モル)、ジメチルアニリン13.3g
(0.11モル)および無水ベンゼン35mlの溶液を調
製する。こ溶液に5−メチルイソキサゾリル−3
−カルボニルクロリド14.5g(0.1モル)を滴下
する。
Example 2 In a flask, β-phenylethylamine
12.11g (0.1 mol), dimethylaniline 13.3g
(0.11 mol) and 35 ml of anhydrous benzene. Add 5-methylisoxazolyl-3 to this solution.
- 14.5 g (0.1 mol) of carbonyl chloride are added dropwise.

該溶液を70℃の急速加熱後、室温まで冷却す
る。フラスコ内容物を減圧濾過ベンゼン溶液を蒸
発乾固する。
The solution is rapidly heated to 70°C and then cooled to room temperature. The contents of the flask are filtered under reduced pressure and the benzene solution is evaporated to dryness.

残渣22.5gをエタノール中で再結晶してN−
(β−フエニルエチル)−5−メチルイソキサゾリ
ル−3−カルボキシアミド(融点89〜90℃)から
なる中間生成物19g(理論値に対して収量82.5
%)を得る。
22.5 g of the residue was recrystallized in ethanol to give N-
19 g of intermediate product consisting of (β-phenylethyl)-5-methylisoxazolyl-3-carboxamide (melting point 89-90°C) (yield 82.5 based on theoretical value)
%).

中間生成物を実施例1記載と同様に処理して、
同じカルボキシアミドエチルベンゼン−4−スル
ホンアミド()を得た。
The intermediate product was treated as described in Example 1,
The same carboxamidoethylbenzene-4-sulfonamide () was obtained.

本発明が例示として上述した好適な実施態様に
限定されず、かつ当業者が本発明の範囲および精
神から逸脱することなく種々の変形および種々の
変更をもたらすことができることが理解されよ
う。
It will be understood that the invention is not limited to the preferred embodiments described above by way of example, and that those skilled in the art can make various modifications and changes without departing from the scope and spirit of the invention.

Claims (1)

【特許請求の範囲】 1 血糖低下作用を有するスルホニル尿素の製造
に有用なカルボキシアミドエチルベンゼン−4−
スルホンアミドの製法において、以下の工程、す
なわち、 (a) β−フエニルエチルアミンを酸
【式】の塩化物と反応させ て、 一般式 で表される中間生成物を得、 (b) クロルスルホン酸により該中間生成物()
をスルホン化し、 (c) 前記中間生成物のスルホクロル化物を濃アン
モニアによりアミド化して、一般式 で表されるカルボキシアミドエチルベンゼン−
4−スルホンアミドを得る、 ことを含むことを特徴とするカルボキシアミドエ
チルベンゼン−4−スルホンアミドの製造方法。
[Scope of Claims] 1. Carboxamidoethylbenzene-4- useful for producing sulfonylurea having hypoglycemic effect
In the method for producing sulfonamides, the following steps are carried out: (a) β-phenylethylamine is reacted with the chloride of the acid [formula] to form a compound of the general formula (b) converting the intermediate product ( ) with chlorosulfonic acid;
(c) The sulfochloride of the intermediate product is amidated with concentrated ammonia to obtain the general formula Carboxamidoethylbenzene represented by
A method for producing carboxyamidoethylbenzene-4-sulfonamide, comprising: obtaining 4-sulfonamide.
JP1018280A 1979-06-14 1980-02-01 Manufacture of carboxyamidoethylbenzenee44sulfonamide Granted JPS55167278A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT7923578A IT1121577B (en) 1979-06-14 1979-06-14 PROCEDURE FOR THE PRODUCTION OF CARBOXAMIDE-ETHYLBENZEN-4-4SULPHONAMIDS

Publications (2)

Publication Number Publication Date
JPS55167278A JPS55167278A (en) 1980-12-26
JPH0215544B2 true JPH0215544B2 (en) 1990-04-12

Family

ID=11208273

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1018280A Granted JPS55167278A (en) 1979-06-14 1980-02-01 Manufacture of carboxyamidoethylbenzenee44sulfonamide

Country Status (4)

Country Link
JP (1) JPS55167278A (en)
DE (1) DE2950380A1 (en)
FR (1) FR2459237A1 (en)
IT (1) IT1121577B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201047A1 (en) * 1992-01-17 1993-07-22 Bayer Ag SUBSTITUTED ISOXAZOLE CARBONIC ACID AMIDES

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51136646A (en) * 1975-04-18 1976-11-26 Boehringer Mannheim Gmbh Production of phenylalkane carboxylic acid and blood sugar and lipid lowering agent containing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH516578A (en) * 1967-11-02 1971-12-15 Bayer Ag Process for the preparation of arylsulfonylureas containing heterocyclic acylamino groups and having an antihypertensive effect
DE1679952A1 (en) * 1967-11-11 1971-06-09 Basf Ag Process for the production of molded articles from polyamides
US3965173A (en) * 1971-05-21 1976-06-22 Chubb Francis L Process for preparing p-(5-chloro-2-methoxy-benzamidoethyl)-benzene sulfonamide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51136646A (en) * 1975-04-18 1976-11-26 Boehringer Mannheim Gmbh Production of phenylalkane carboxylic acid and blood sugar and lipid lowering agent containing same

Also Published As

Publication number Publication date
JPS55167278A (en) 1980-12-26
IT7923578A0 (en) 1979-06-14
DE2950380A1 (en) 1980-12-18
FR2459237A1 (en) 1981-01-09
IT1121577B (en) 1986-04-02
FR2459237B1 (en) 1983-10-14

Similar Documents

Publication Publication Date Title
JPH0215544B2 (en)
US2519038A (en) Production of lysine and intermediates
CN111153866A (en) Parecoxib sodium disubstituted impurity and preparation method and application thereof
NO135092B (en)
KR890002251B1 (en) Process for preparing oxazole compound
JPH069543A (en) Production of chlorosulfonylated product
JPS5927343B2 (en) Synthesis method of 3-aminoisoxazoles
HU194815B (en) Process for preparing n-arylformamidine derivatives
SU785305A1 (en) Method of preparing trans-1-aryl(alkyl)sulfonyl-2-dialkylaminoethenes
KR910006126B1 (en) Preparation process of n-(3-(3-cl-pyperidynyl methyl)phenoxy)propyl)-acetoxyacetate amid
KR800000486B1 (en) Process for the preparation of n-(diethylamino-ethyl)2-methoxy-4-amino 5-chlorobenzamide
JPH01102064A (en) Production of halogenopyridine carboxylic acid amides
JPH0253784A (en) Production of alpha-substituted-gamma-butyrolactones
KR100516383B1 (en) New manufacturing process of dihydrocarbostyril derivatives
KR100302347B1 (en) A process for preparing nizatidine
JPS5935369B2 (en) Stereoselective synthesis method for optically active compounds
KR900004400B1 (en) Process for the preparation of halogened carbanilide
DK144913B (en) 3-THIENYLACETONITRILS USED AS INTERMEDIATES FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE SIMILAR AMINOAL CYCLESTERS OF ALFA - SUBSTITUTED 3-THIENYL ACETIC ACID
JPS58164571A (en) Manufacture of 1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-3-indole acetoxyacetic acids
JPS589106B2 (en) Fukusokanshikikagobutsunoseiho
JPS5844661B2 (en) Isocyanthane 3-Isoxazolyl ester
JPS5910657B2 (en) Method for producing benzoic acid derivatives
JPS60115567A (en) Production of 3-aminoisoxazole
JPH0328423B2 (en)
JPH0120150B2 (en)